© 2016 Dr Alexander DavenportDespite the success of autologous chimeric antigen receptor (CAR) T cells to treat patients with refractory B cell acute lymphoblastic leukaemia, (ALL) and lymphoma, there are many aspects of CAR T cell biology that remains unknown. For this reason, this thesis explored whether the recognition of antigen via either antigen receptor (CAR vs endogenous T cell receptor (TCR)) affected the CAR-T cell immune synapse, receptor signalling and tumour target killing kinetics. By addressing this issue we aim to translate this new knowledge to the clinic and broaden the CAR T therapy success to patients with a wider range of cancer subtypes. To explore the above questions, a novel transgenic mouse (designated CAR.OT-I) was...
International audienceAdoptive transfer of T cells genetically engineered to express chimeric antige...
Chimeric antigen receptors (CARs) can mediate redirected lysis of tumour cells in a major histocompa...
The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a pro...
Adoptive therapy with chimeric antigen receptor (CAR) T cells shows great promise clinically. Howeve...
Chimeric antigen receptor T (CAR-T) cells are effective serial killers with a faster off-rate from d...
Effective adoptive T cell therapy (ACT) comprises the killing of cancer cells through the therapeuti...
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. ...
© 2021 Nicholas John ChandlerChimeric antigen receptor (CAR) T cell therapy has revolutionized the t...
T cell-based immunotherapy has demonstrated great therapeutic potential in recent decades, on the on...
© 2014 Dr. Connie DuongAdoptive immunotherapy is a promising treatment for cancer, with response rat...
While the clinical progress of chimeric antigen receptor T cell (CAR-T) immunotherapy has garnered a...
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatm...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Abstract Adoptive cell therapy using chimeric antigen receptor (CAR)-engineered T cells has emerged ...
International audienceAdoptive transfer of T cells genetically engineered to express chimeric antige...
Chimeric antigen receptors (CARs) can mediate redirected lysis of tumour cells in a major histocompa...
The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a pro...
Adoptive therapy with chimeric antigen receptor (CAR) T cells shows great promise clinically. Howeve...
Chimeric antigen receptor T (CAR-T) cells are effective serial killers with a faster off-rate from d...
Effective adoptive T cell therapy (ACT) comprises the killing of cancer cells through the therapeuti...
Chimeric antigen receptor (CAR) T cell immunotherapy is a revolutionary pillar in cancer treatment. ...
© 2021 Nicholas John ChandlerChimeric antigen receptor (CAR) T cell therapy has revolutionized the t...
T cell-based immunotherapy has demonstrated great therapeutic potential in recent decades, on the on...
© 2014 Dr. Connie DuongAdoptive immunotherapy is a promising treatment for cancer, with response rat...
While the clinical progress of chimeric antigen receptor T cell (CAR-T) immunotherapy has garnered a...
T cell engineering strategies have emerged as successful immunotherapeutic approaches for the treatm...
Chimeric antigen receptors (CAR) are genetically engineered receptors that can recognise specific an...
Background: T cells expressing chimeric antigen receptors (CARs) have shown exciting promise in canc...
Abstract Adoptive cell therapy using chimeric antigen receptor (CAR)-engineered T cells has emerged ...
International audienceAdoptive transfer of T cells genetically engineered to express chimeric antige...
Chimeric antigen receptors (CARs) can mediate redirected lysis of tumour cells in a major histocompa...
The adoptive transfer of T lymphocytes expressing chimeric antigen receptors (CARs) has become a pro...